Market Access, Pricing, and Reimbursement of Drugs and Devices: Legal Principles and Practice (Non-Members)
This brand new title provides a deep dive into drug and device development and distribution.
Select a format
Select subscription type
Terms & conditions
Subscribers receive the product(s) listed on the Order Form and any Updates made available during the annual subscription period. Shipping and handling fees are not included in the annual price.
Subscribers are advised of the number of Updates that were made to the particular publication the prior year. The number of Updates may vary due to developments in the law and other publishing issues, but subscribers may use this as a rough estimate of future shipments. Subscribers may call Customer Support at 800-833-9844 for additional information.
Subscribers may cancel this subscription by: calling Customer Support at 800-833-9844; emailing email@example.com; or returning the invoice marked "CANCEL".
If subscribers cancel within 30 days after the product is ordered or received and return the product at their expense, then they will receive a full credit of the price for the annual subscription.
If subscribers cancel between 31 and 60 days after the invoice date and return the product at their expense, then they will receive a 5/6th credit of the price for the annual subscription. No credit will be given for cancellations more than 60 days after the invoice date. To receive any credit, subscriber must return all product(s) shipped during the year at their expense within the applicable cancellation period listed above.
Market Access, Pricing, and Reimbursement of Drugs and Devices: Legal Principles and Practice is a brand new publication that provides a uniquely comprehensive examination of the legal and business considerations relating to drug and device manufacturing and distribution, including market access, pricing, reimbursement, and promotion.
Each chapter provides a strong foundation for understanding medical product market access, as well as advanced topics for readers who have been practicing in the pharmaceutical and device industry for many years.
The treatise has been drafted with both new and experienced market access practitioners in mind. Although written through a lens of advising life sciences companies engaging in market access activities, Market Access, Pricing, and Reimbursement of Drugs and Devices: Legal Principles and Practice will also prove useful to stakeholders across the medical product supply chain—from manufacturers to distributors to payers to health care providers to government regulators—and the numerous additional entities that facilitate access to and distribution of medical products.
EDITORS: Rujul H. Desai, Stefanie A. Doebler, Kristie C. Gurley and Anna D. Kraus.
AUTHORS: Shruti C. Barker, Beth Braiterman, Elizabeth Brim, Tara Carrier, Andrew B. Do, Matthew F. Dunn, Daniel Grant, Alexander B. Hastings, Claire C. Jacob, Mingham Ji, Sanchi Khare, Caitlin E. Koury, Michael S. Labson, Kassandra Maldonado, Krysten Rosen Moller, Raymond Ngu, Jennifer L. Plitsch, Molly Ramsden, Kendra L. Roberson, Tiffany P. Rodriguez, Sarah M. Schuler, Chelsea Segal, Olivia Vega, and Allison Whelan.
For full author bios, please click here.
eBooks, CDs, downloadable content, and software purchases are noncancelable, nonrefundable and nonreturnable. Click here for more information about LexisNexis eBooks. The eBook versions of this title may feature links to Lexis+® service for further legal research options. A valid subscription to Lexis+ is required to access this content.
Published in March 2023.
Table of contents
Recent Titles from the American Health Law Association
About the Editors
About the Authors
About the American Health Law Association
Table of Acronyms
PART I MECHANICS OF PRICING AND REIMBURSEMENT
Chapter 1: U.S. Market Access Framework
Chapter 2: Drugs and Biologics Pricing and Reimbursement
Chapter 3: Medical Devices and Diagnostics Pricing and Reimbursement
Chapter 4: Government Price Reporting
Chapter 5: Commercial Channel
Chapter 6: Government Purchaser Channel
PART II COMPLIANCE AND PROMOTION
Chapter 7: Fraud, Waste, and Abuse Issues
Chapter 8: Communications with Payers
Chapter 9: Support for Patients
PART III EMERGING TRENDS
Chapter 10: Measuring and Contracting for Value
Chapter 11: State Market Access and Drug Pricing Laws
Table of Acronyms